Trade JANX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Janux Therapeutics, Inc. (JANX) is trading at US$17.47, up 2.70% today as of Sep 22, 16:00 EDT. The company has a market capitalisation of US$1.06B. Over the past 52 weeks, JANX has traded between US$12.12 and US$35.34. On Syfe you can trade JANX with $0 commission and add it to your watchlist.
| Previous close | US$17.01 |
|---|---|
| Market cap | US$1.06B |
| 52-week range | US$12.12 – US$35.34 |
| Volume | 825.86K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Janux Therapeutics, Inc.
Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded by David Campbell in June 2017 and is headquartered in San Diego, CA.
Year: 2021
Janus Living Prices Share Offering
Aug 11, 8:18 AM · MT Newswires
RBC Adjusts Price Target on Janux Therapeutics to $34 From $30, Maintains Outperform Rating
Aug 10, 11:21 AM · MT Newswires
-- Earnings Flash (JANX) Janux Therapeutics, Inc. Reports Q2 Revenue $10.3M, vs. FactSet Est of $19.1M
Aug 6, 8:14 PM · MT Newswires
RBC Raises Janux Therapeutics Price Target to $30 From $27, Keeps Outperform Rating
May 8, 4:44 PM · MT Newswires
Janux Therapeutics, Inc. (JANX) stock is trading at US$17.47, +2.70% from the previous close of US$17.01.
The market cap for Janux Therapeutics, Inc. (JANX) stock is approximately US$1.06B.
The 52-week high for Janux Therapeutics, Inc. (JANX) stock is US$35.34.
The 52-week low for Janux Therapeutics, Inc. (JANX) stock is US$12.12.
Janux Therapeutics, Inc. (JANX) does not currently pay a dividend.
Stay on top of JANX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
